Lenacapavir is a drug that has been approved by the U.S. Food and Drug Administration (FDA) under the brand name Sunlenca for the treatment of HIV.4 Lenacapavir ...

10 июл. 2024 г. · Twice-yearly injections of Lenacapavir showed overwhelming efficacy for preventing HIV infections compared to standard oral preventative HIV ...

6 мар. 2024 г. · A once-weekly oral regimen can keep HIV suppressed as well as daily pills, according to study results presented today at the Conference on Retroviruses and ...

12 сент. 2024 г. · The use of lenacapavir for the prevention of HIV is investigational and has not been determined to be safe or efficacious and is not approved ...

17 сент. 2024 г. · In newly released data, lenacapavir, given via a twice-yearly injection, has shown remarkable effectiveness at eliminating HIV transmission ...

HIV medicines cannot cure HIV/AIDS, but taking HIV medicines every day helps people with HIV live longer, healthier lives.

Lenacapavir is meant to be used as part of combination therapy for people who have HIV that is resistant to many treatments. Researchers refer to this group of ...

26 июл. 2024 г. · Long-acting injectable lenacapavir as pre-exposure prophylaxis (PrEP) is highly effective in preventing HIV acquisition in women.

30 авг. 2023 г. · Lenacapavir is a new FDA-approved HIV injection that is safe, highly effective, and taken only twice per year. Its approval was based on ...

20 июн. 2024 г. · “With zero infections and 100% efficacy, twice-yearly lenacapavir has demonstrated its potential as an important new tool to help prevent HIV ...